EUROPEAN UNION

Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA

Retrieved on:

Lunedì, Aprile 1, 2024

Biogen, FDA, Brain, Administration, MCI, State, Fast Track, Dementia, Cell, Clarity, Eisai, Biologics license application, European, Alzheimer's disease, OLE, Patient, BLA, Neuron, Plaque, Lecanemab

LEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment or mild dementia stage of disease (collectively referred to as early AD).

Key Points:

LEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment or mild dementia stage of disease (collectively referred to as early AD).
Eisai had aimed to submit a Biologics License Application (BLA) for weekly maintenance therapy using subcutaneous (SC) administration in March 2024.
However, Eisai was recently informed by the FDA that a Fast Track designation specific for the SC formulation is needed to receive rolling review.
Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials.

Fosun's Next Step: "Deep Mining" for Stable Profits

Retrieved on:

Giovedì, Marzo 28, 2024

With the implementation of the business streamlining strategy, Fosun divested some non-core businesses that had previously provided stable cash flows.

Key Points:

With the implementation of the business streamlining strategy, Fosun divested some non-core businesses that had previously provided stable cash flows.
The subsequent improvement in cash flow has brought market attention to how Fosun will sustain stable profit growth as it did over the past decade.
The results announcement shows that Fosun's focus on its core businesses in the household consumption sector has gradually yielded results.
Leveraging on the two core growth drivers of innovation and globalization, Fosun has continued to deepen its efforts in advantageous industries and reap more stable profits.

Xencor Reports First Quarter 2024 Financial Results

Retrieved on:

Giovedì, Maggio 9, 2024

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a review of recent clinical and business highlights.

Key Points:

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a review of recent clinical and business highlights.
New Chief Financial Officer Appointed: Bart Cornelissen was appointed as Xencor’s senior vice president and chief financial officer.
Financial Results for the First Quarter Ended March 31, 2024
Cash, cash equivalents and marketable debt securities totaled $646.7 million as of March 31, 2024, compared to $697.4 million on December 31, 2023.
Revenues for the first quarter ended March 31, 2024 were $12.8 million, compared to $19.0 million for the same period in 2023.

China, France to consolidate relationship

Retrieved on:

Giovedì, Maggio 9, 2024

During their talks, the two presidents highlighted the countries' friendly relationship as well as the potential and prospects of cooperation.

Key Points:

During their talks, the two presidents highlighted the countries' friendly relationship as well as the potential and prospects of cooperation.
He also pledged to increase dialogue and communication with France in areas including AI governance and reform of the international financial system.
Macron assured Xi that France will continue to open its market to China and will not adopt discriminatory policies against Chinese companies.
Xi and Macron also met on Tuesday at Col du Tourmalet in southwestern France, before Xi left for a state visit to Serbia.

China, France to consolidate relationship

Retrieved on:

Giovedì, Maggio 9, 2024

During their talks, the two presidents highlighted the countries' friendly relationship as well as the potential and prospects of cooperation.

Key Points:

During their talks, the two presidents highlighted the countries' friendly relationship as well as the potential and prospects of cooperation.
He also pledged to increase dialogue and communication with France in areas including AI governance and reform of the international financial system.
Macron assured Xi that France will continue to open its market to China and will not adopt discriminatory policies against Chinese companies.
Xi and Macron also met on Tuesday at Col du Tourmalet in southwestern France, before Xi left for a state visit to Serbia.

Statement by the Prime Minister on Europe Day

Retrieved on:

Giovedì, Maggio 9, 2024

United Nations, Climate change, Europe Day, Health, Heart, Friends, European, United, Aggression, Military, Democracy

OTTAWA, ON, May 9, 2024 /CNW/ - The Prime Minister, Justin Trudeau, today issued the following statement on Europe Day:

Key Points:

OTTAWA, ON, May 9, 2024 /CNW/ - The Prime Minister, Justin Trudeau, today issued the following statement on Europe Day:
"Today, on Europe Day, we join our friends in Europe and around the world to celebrate the ongoing success of the European Union (EU) and the values of democracy, peace, and unity it upholds.
"Europe Day reminds us that we are stronger when we work together.
From the World Wars to the United Nations, to trade, innovation, health, and so much more – Canada and Europe will always be close partners.
Happy Europe Day!"

Volet.com launches new prepaid cards

Retrieved on:

Giovedì, Maggio 9, 2024

USD, European, KYC, AML, POS, ATM, Cryptocurrency

QUEBEC CITY, May 9, 2024 /PRNewswire/ -- Volet.com payment platform announces the launch of its prepaid cards in USD available in most supported countries, making these cards the company's product with the widest international coverage. Existing Volet.com cards usually target specific regions and countries, like its most popular Europe cards for the European Union and a few select countries outside the EU. The new Global Plus cards are available to verified Volet.com users in most supported countries in Europe, Latin America, Asia, Africa and more.

Key Points:

Volet.com, the internationally renowned e-wallet provider, launches new Global Plus prepaid cards for international customers.
QUEBEC CITY, May 9, 2024 /PRNewswire/ -- Volet.com payment platform announces the launch of its prepaid cards in USD available in most supported countries, making these cards the company's product with the widest international coverage.
According to the information available within the Volet.com platform, all prepaid cards are only offered to verified users.
Volet.com prepaid cards help users make international POS and ATM payments.

Fuller, Smith & Turner PLC: Transaction in own shares

Retrieved on:

Venerdì, Maggio 10, 2024

FCA, Transparency, Disclosure, Security (finance)

The Company intends to hold the repurchased shares in Treasury.

Key Points:

The Company intends to hold the repurchased shares in Treasury.
Following the purchase of the said shares, Fuller’s listed issued share capital consists of 41,182,339 ‘A’ ordinary shares of 40p each.
Of this total, 4,461,581 A’ ordinary shares are held in treasury.
Therefore, the total number of listed voting rights in the Company for the purpose of Disclosure and Transparency Rule 5.6.1 (calculated in accordance with Disclosure and Transparency Rule 5.6.2) is 36,720,758.

Fuller, Smith & Turner PLC: Transaction in own shares

Retrieved on:

Venerdì, Maggio 10, 2024

FCA, Transparency, Disclosure, Security (finance)

The Company intends to hold the repurchased shares in Treasury.

Key Points:

The Company intends to hold the repurchased shares in Treasury.
Following the purchase of the said shares, Fuller’s listed issued share capital consists of 41,182,339 ‘A’ ordinary shares of 40p each.
Of this total, 4,443,541 A’ ordinary shares are held in treasury.
Therefore, the total number of listed voting rights in the Company for the purpose of Disclosure and Transparency Rule 5.6.1 (calculated in accordance with Disclosure and Transparency Rule 5.6.2) is 36,738,258.

Funding Circle Plc: POS-Transaction in Own Shares

Retrieved on:

Venerdì, Maggio 10, 2024

London Stock Exchange, FCA, Share repurchase, Retained firefighter, The Company

Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024:

Key Points:

Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024:
Number of ordinary shares purchased:
Highest price paid per share:
Lowest price paid per share:
Volume weighted average price paid per share:
The Company intends to cancel all of the purchased ordinary shares.
Following the cancellation of the repurchased shares, the Company's issued share capital will consist of 355,099,011 ordinary shares with voting rights.
There are no ordinary shares held in Treasury.
The above figure (355,099,011) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.